Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30.

This paper describes the physical stability of solid dispersions of UC-781 with PEG 6000, Gelucire 44/14 and PVP K30 prepared by the solvent and melting methods. The concentration of the drug in the solid dispersions ranged from 5 to 80% w/w. The solid dispersions were stored at 4-8 and 25 degrees C (25% RH), then their physicochemical properties were analysed by differential scanning calorimetry (DSC), X-ray powder diffraction and dissolution studies as a function of storage time. The DSC curves of solid dispersions of UC-781 with PVP K30 did not show any melting peaks corresponding to UC-781 after storage, indicating no recrystallization of the drug. The DSC data obtained from PEG 6000 and Gelucire 44/14 showed some variations in melting peak temperatures and enthalpy of fusion of the carriers. It was shown that the enthalpy of fusion of PEG 6000 in the dispersions increased after storage; it was more pronounced for samples stored at 25 degrees C compared to those at 4-8 degrees C indicating the reorganization of the crystalline domains of the polymer. Similarly, the enthalpy of fusion of Gelucire 44/14 in the solid dispersions increased as a function of time. Dissolution of UC-781 from all solid dispersions decreased as a function of storage time. While these observations concurred with the DSC data for all solid dispersions, they were not reflected by X-ray powder diffraction data. It was concluded that it is the change of the physical state of the carriers and not that of the drug, which is responsible for the decreased dissolution properties of the solid dispersions investigated.

[1]  Bruno C. Hancock,et al.  Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. , 1995, Journal of pharmaceutical sciences.

[2]  S. Yoshioka,et al.  Physical Stability and Protein Stability of Freeze-Dried Cakes During Storage at Elevated Temperatures , 1994, Pharmaceutical Research.

[3]  Bruno C. Hancock,et al.  Characteristics and significance of the amorphous state in pharmaceutical systems. , 1997, Journal of pharmaceutical sciences.

[4]  M. Anttila,et al.  A Comparison of the Biovailability of Paracetamol from a Fatty and a Hydrous Suppository Base and the Effect of Storage on the Absorption in Man , 1987 .

[5]  M. H. Rubinstein,et al.  Preformulation Studies on Solid Dispersions Containing Triamterene or Temazepam in Polyethylene Glycols or Gelucire 44/14 for Liquid Filling of Hard Gelatin Capsules , 1991 .

[6]  S. Yamamura,et al.  Some physicochemical properties of glassy indomethacin. , 1986, Chemical & pharmaceutical bulletin.

[7]  A. Nuñez,et al.  Accelerated stability study of sustained-release nifedipine tablets prepared with Gelucire , 1992 .

[8]  E. De Clercq,et al.  Identification of novel thiocarboxanilide derivatives that suppress a variety of drug-resistant mutant human immunodeficiency virus type 1 strains at a potency similar to that for wild-type virus , 1996, Antimicrobial agents and chemotherapy.

[9]  Ford Jl,et al.  Formulation and ageing of tablets prepared from indomethacin-polyethylene glycol 6000 solid dispersions. , 1980 .

[10]  Y. Kawashima,et al.  Temperature- and Moisture-Induced Crystallization of Amorphous Lactose in Composite Particles with Sodium Alginate Prepared by Spray-Drying , 2000, Pharmaceutical development and technology.

[11]  I. Sugimoto,et al.  Stability of Nifedipine-polyvinylpyrrolidone coprecipitate. , 1981, Chemical & pharmaceutical bulletin.

[12]  Ford Jl,et al.  Ageing of indomethacin-polyethylene glycol 6000 solid dispersion. , 1979 .

[13]  L. Naesens,et al.  Solid state properties of pure UC‐781 and solid dispersions with polyvinylpyrrolidone (PVP K30) , 2001, The Journal of pharmacy and pharmacology.

[14]  M. H. Rubinstein,et al.  Physical Stability of Solid Dispersions Containing Triamterene or Temazepam in Polyethylene Glycols , 1997, The Journal of pharmacy and pharmacology.

[15]  A. Mrhar,et al.  Sustained release nifedipine formulations: Moment, Modelling and Simulation as pharmacokinetic analysis approach , 1992 .

[16]  C. A. Hirsch,et al.  Solid dispersion approach for overcoming bioavailability problems due to polymorphism of nabilone, a cannabinoid derivative , 1977, The Journal of pharmacy and pharmacology.

[17]  I. Sugimoto,et al.  Dissolution and Absorption of Nipedipine from Nifedipine-Polyvinylpyrrolidone Coprecipitate , 1980 .